CEO Josh Disbrow reported that both the ADHD and pediatric portfolios achieved sequential prescription growth for the first time since late 2022. ADHD net revenue reached $13.8 million, while the ...

For years, stimulant medications for ADHD have been described as chemical accelerators, framed as drugs that rev up a ...

The findings suggest that short-term treatment of ADHD with stimulant medication is well justified by benefits that outweigh costs, but long-term treatment may be associated with growth-related costs ...

Managing time effectively can be a Herculean task for almost everyone. A person with ADD or ADHA (Attention Deficit Hyperactivity Disorder), however, often finds themselves facing a Mt. Olympus-size ...